Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity: An Untargeted T Cell Population" (# 859869783).

NCT01914354 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT01914354
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01914354 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of CD28null NKG2Dpos T Cells on Human Alloimmune Reactivity: An Untargeted T Cell Population" (# 859869783).
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Completed
Start date
February 29, 2012
Completion date
June 30, 2014
Enrollment
90 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant